The Obama administration approved the first three Alzheimer’s drugs Thursday, one of which is the first to treat a protein found in the brain that can trigger Alzheimer’s.
The approval came from the Food and Drug Administration, which said the drugs can help slow the progression of Alzheimer’s disease and help fight the spread of the disease in younger people.
“This is a groundbreaking step forward for patients with advanced Alzheimer’s,” said Dr. Joseph Raskin, director of the Alzheimer’s Disease Research Center at the Mayo Clinic.
“These drugs offer a significant new option for those suffering from Alzheimer’s.”
The drugs, which were approved for patients age 60 and older, are already available to seniors.
The approval of the drug was approved in an advisory committee meeting.
The FDA has said it plans to approve the drugs for patients younger than 60.
Dr. Daniel Novella, the chief executive officer of Alzheimer Disease Genetics, a biotech company, said he was excited about the news.
“This drug has been on my wish list for a long time and now it’s finally coming,” Novellasaid.
He said that it could be the first drug that can prevent or slow the disease.
“We have a lot of exciting research coming out of this area, but I think this will be a very important step in the fight against Alzheimer’s by providing a new tool for patients,” Novsaid said.
This article has been updated with the names of the drugs approved Thursday.